Metagenomi (MGX) News Today → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free MGX Stock Alerts $7.53 +0.79 (+11.72%) (As of 04/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMetagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Buy" by Analystsamericanbankingnews.com - April 24 at 2:32 AMMetagenomi to Present at Upcoming Scientific Meetingsglobenewswire.com - April 8 at 8:00 AMMetagenomi, Inc. Expected to Earn FY2024 Earnings of ($2.44) Per Share (NASDAQ:MGX)marketbeat.com - April 4 at 9:14 AMMetagenomi (NASDAQ: MGX)fool.com - April 3 at 3:54 AMMetagenomi Inc MGXmorningstar.com - April 2 at 5:53 PMMetagenomi, Inc.: Strong Buy Rating on Robust Hemophilia Program and Strategic Partnershipsmarkets.businessinsider.com - March 29 at 4:47 AMMetagenomi, Inc.: Strong Buy Rating on Promising Pipeline and Solid Financial Positioningmarkets.businessinsider.com - March 29 at 4:47 AMMetagenomi, Inc.: Metagenomi Reports Business Updates and Full Year 2023 Financial Resultsfinanznachrichten.de - March 28 at 6:44 PMMetagenomi (NASDAQ:MGX) Stock Rating Reaffirmed by Chardan Capitalmarketbeat.com - March 28 at 8:28 AMMetagenomi reports FY resultsmsn.com - March 27 at 12:31 PMMetagenomi Reports Business Updates and Full Year 2023 Financial Resultsglobenewswire.com - March 27 at 9:16 AMMetagenomi, Inc. (NASDAQ:MGX) Given Consensus Rating of "Buy" by Brokeragesmarketbeat.com - March 5 at 10:05 AMMetagenomi (NASDAQ:MGX) Coverage Initiated at TD Cowenmarketbeat.com - March 5 at 8:18 AMMetagenomi to Participate in the 44th Annual Cowen Healthcare Conferenceglobenewswire.com - February 29 at 4:30 PMThis Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yetfool.com - February 19 at 10:30 AMInsider Buying: Taking a Controlling Stake in a Struggling Retailer?247wallst.com - February 18 at 11:20 AMMetagenomi Announces Closing of Initial Public Offeringglobenewswire.com - February 13 at 4:35 PMModerna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debutreuters.com - February 9 at 2:34 PM Get Metagenomi News Delivered to You Automatically Sign up to receive the latest news and ratings for MGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> MGX Media Mentions By Week MGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MGX News Sentiment▼1.020.32▲Average Medical News Sentiment MGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MGX Articles This Week▼11▲MGX Articles Average Week Get Metagenomi News Delivered to You Automatically Sign up to receive the latest news and ratings for MGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Fennec Pharmaceuticals News Today Invivyd News Today Black Diamond Therapeutics News Today Monte Rosa Therapeutics News Today Anavex Life Sciences News Today Coherus BioSciences News Today Sutro Biopharma News Today Opthea News Today Century Therapeutics News Today Compass Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MGX) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithJeff Bezos Just Humiliated Elon MuskInvestorPlaceBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metagenomi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
